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1. Introduction
Nanotechnology is the science of manipulating matter where at least one dimension is in the
nano-scale. Nanotechnology is a very promising field to the medicinal and pharmaceutical
sectors, hence, it plays an important role in enhancing humanity’s quality of life. Nanotech‐
nology has many applications in the medical sector, including diagnosis and therapeutic.
However, therapeutic uses are considered the main application of nanotechnology in the
health sector. Nanotechnology has an important impact on improving therapeutics by
facilitating drug delivery, increasing the efficacy of the drug, improving its circulation and
stability in addition to decreasing its toxic side effects [1]. Most active compounds that are
proven to have certain effects to treat certain ailments or alleviate pain can be categorized as
organic compounds. Most active organic compounds are insoluble in aqueous media, have
poor bioavailability, instable and most of the time are toxic.
Herbal medicines, or active compounds derived from natural sources suffer from the same
limitations of many other drugs [2]. However, in the case of synthesized drugs, many of these
problems can be overcome by preparing derivatives of these drugs that retain some of their
activities and at the same time enhancing their physical properties to a more suitable form for
pharmaceutical formulations. However, herbal medicines are still the main source of drugs
and their side effects are much lower than their synthetic counterparts, add to this a deep and
strongly rooted trust in many societies in their efficacy to heal or prevent diseases, even though
most of the time not proven in a scientific and systematic way. In order to overcome such
limitations, many techniques have been employed such as solubilization in a non-polar
solvent, preparing them as an injection and/or converting the active ingredients into their salt
form in order to enhance their solubility in aqueous medium. However, these methodologies
also suffer from various disadvantages. These include the toxicity of the solubilizing agent,
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the actual or real activity of the salt form, the need for further studies to insure the presence
of the bioactive form of the drug and the extent of its bioavailability. In this aspect, nanotech‐
nology is a very promising tool for enhancing the use of herbal medicines, or in more accurate
words, to re-discover their full potential in pharmaceutical formulation. Extensive libraries of
nanoparticles-that can be used for the delivery of natural bioactive compounds to a certain
target-have been studied. These different nanoparticles can be designed, prepared in different
shapes, sizes, compositions, functionalized and modified chemically/physically to suite
specific properties depending on the characteristics of both the drug and the targeted organ.
These nanoparticles can be anything from emulsion and micro-emulsions, dendrimers,
fullerenes, liquid crystals, quantum dots, nano rods, solid lipid nanoparticles (SLN), lipo‐
somes, gels and many other different types.
In this chapter, a brief focus on herbal medicines, nanotechnological approaches to enhance
their promised action will be reviewed and discussed. At the end, successful stories of
nanoparticle loaded active phytochemicals that reached the market will be presented as case
studies in this field.
2. Herbal medicine
Natural products chemistry is one of the oldest sciences sought for medicine throughout the
history of mankind. Its roots dates back in time, thousands of years ago, through the use of
many herbal mixtures as remedies for many diseases. It was clear from the beginning that
certain herbs, plants, etc… have certain positive influence when used as remedies for sickness,
but it was unclear how the mechanism of remedy was attained. As a consequence of the
accumulation of many years of knowledge, traditional medicine has come forth to group,
organize and categorize these remedies according to their effects on diseases, whereby,
biomedicine and chemistry came to shed more light on the active ingredients of these folk
remedies and on the mechanism of their action.
Currently, natural product chemistry has evolved to be an interdisciplinary area of science,
concerned with the isolation, characterization and determination of the biological activity of
the pure phytochemicals. These active components, generally referred to as secondary
metabolites, include phenolics, terpenoids, alkaloids and steroids. Even though it has been
proved that many natural products have a strong therapeutic value, limitations related to their
poor solubility and bioavailability in addition to toxicity and stability have severely hindered
their use as drugs [3]. According to U.S. Food and Drug Administration (FDA), the definition
of bioavailability is “the rate and extent to which the active ingredient or active moiety is
absorbed from a drug product and becomes available at the site of action” [4].
3. Phenolic compounds
Natural phenolic compounds are secondary metabolites present in all vascular plants and
embracing a vast range of aromatic organic compounds with one or more hydroxyl substitu‐
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ent(s). The parent compound is phenol but most of these naturally occurring compounds are
polyphenolics, which to date, exceeds 8000 structurally identified compounds. Plant polyphe‐
nolics are grouped into different classes depending on their chemical structure. Flavanoids are
the largest and most important group of natural polyphenolics with more than 6000 molecules
identified so far. Other classes include phenolic quinones, lignans, xanthones, coumarines,
polymeric lignins and tanins [5]. Within each class of compounds, the variations around the
basic chemical skeleton essentially concern the degrees of oxidation, hydroxylation, methyla‐
tion, glycosylation and the possible connections to other molecules (primary metabolites such
as carbohydrates, lipids, proteins, or phenolic secondary metabolites [6].
Polyphenols were the focus of special attention as a result of the so-called Mediterranean diet
rich in fruits and vegetables. This diet appears to protect against cardiovascular diseases in
addition to potential beneficial health properties, as evidenced by several epidemiological
studies showing that diets rich in fruits and vegetables are generally associated with a lower
cancer incidence and other diseases, such as inflammatory or cardiovascular pathologies [7].
The bioavailability of the orally administrated polyphenols is very low due to their low water
solubility, poor absorption, extensive and rapid metabolism. To overcome these problems,
several bioactive polyphenols were formulated into various pharmaceutical formulations that
could improve their bioavailability.
Among the types of naturally occurring polyphenols, flavonoids (Figure 1) are a large and a
highly diverse group of structurally related secondary metabolites produced by plants. The
main flavonoids subclasses include flavones (Figure 1a), flavonols (Figure 1b), flavans (Figure
1c), flavanones (Figure 1d) in addition to dihidroflavanols (Figure 1e), isoflavons (Figure 1f)
and biflavones. [8].
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Figure 1. Basic structures of some flavonoids’ backbone
Flavonoids received considerable attention due to their wide biological activities. Many of
them are known to possess hepatotoxic, anti-inflammatory, antimicrobial, antiviral, anti-
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allergic and anti-ulcer effects. Also, flavonoids are known to be potent antioxidants with free
radical scavenging abilities [9, 10]. Some flavonoids are known to provide protection against
cardiovascular mortality. Moreover, they have been shown to inhibit the growth of various
cancer cell lines in vitro, and reduce tumor development in experimental animals [11].
Flavanoids, as natural compounds have several great advantages over therapeutic agents
because many diets are rich in flavonoids and polyphenolic compounds [9]. The therapeutic
potential of flavonoids makes them valuable targets for drug design [8].
Lignans (Figure 2) are among the important polyphenolic compounds that are recognized with
a wide spectrum of biological activities. These compounds generally represent a group of
dimeric phenylpropanoids where two C6-C3 are attached by its central carbon C-8.
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Figure 2. Basic structure of lignans: a) Phenylpropanoid unit; b) Lignan structure
Lignans are known for their antiviral, anticancer, cancer prevention, anti-inflammatory,
antimicrobial and antioxidant activities. Also, lignans are known for their immunosuppres‐
sive, hepatoprotective and osterporosis prevention effects. Podophyllotoxin (Figure 3) has
long been known to possess anti-mitotic activity with early clinical trials indicating its high
efficacy. Unfortunately, the toxicity of this compound limits its direct application as a drug
[12]. To solve the problem of toxicity, several modifications were made to the podophyllotoxin
structure in hope of obtaining compounds with low toxicity but retain the desired activities of
the parent compound. Thus, etoposide, teniposide, etopophos and GL-331 were synthesized;
all are potent chemotherapeutic agents for a variety of tumors. Still, etoposide and its analogues
suffer from poor solubility problems.
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Figure 3. Structure of podophyllotoxin
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4. Terpenoids
Terpenoids, as represented by more than 40000 identified compounds, are among the most
widespread group of natural products, with several new compounds being discovered every
year. Terpenes can be generally defined as a group of molecules whose structure is based on
various but definite number of isoprene (3-methyl-1,3-butadiene) units. Based on the number
of isoprene building blocks, terpenoids can be classified into monoterpenes (such as thymo‐
quinone), sesquiterpenes, diterpenes (such as retinol, trans-retonic acid, sclareol), sesterter‐
penes, triterpenes (such as oleanolic and usrolic acids) and tetraterpenes.
From a chemical point of view, terpenoids are usually cyclic unsaturated hydrocarbons, with
different degrees of oxygen in the constituent groups attached to the basic isoprene skeleton.
A wide range of terpenoids have been found to possess preventive and pharmacological
activity against many human ailments including cancer and alzheimer [13, 14]. Several studies
also indicated that terpenoids have antimicrobial, antifungal, antiparasitic, antiviral, anti-
allergenic, anti-spasmodic, antihyperglycemic, anti-inflammatory and immunomodulatory
properties [15].
Monoterpenes are among the best known plant secondary metabolites and are one of the main
classes of terpenoids detected in essential oils, floral scents and defensive resins (both constitu‐
tive and induced) of aromatic plants [16]. A number of monoterpenes have shown antitumor
activity. Examples include thymoquinone (Figure 4), limonene and perilla alcohol. Thymoqui‐
none, which is the main active constituent of the essential oil obtained from the medicinal plant
Nigella  sativa  (commonly referred to  as  Black seeds in  Arabic  countries),  has  interesting
anticancer, anti-oxidant and anti-inflammatory activities both in vivo and in vitro [14, 17, 18, 19]
as well as chemo-preventive properties. The interesting in  vitro  anticancer activity of this
monoterpene against different types of cancer cell lines including human colorectal cancer cells
[13], myeloblastic leukemia cells [20], prostate cancer [17] pancreatic adenocarcinoma [14],
ovarian and breast adenocarcinoma [21] were faced by several limitations that not only hindered
its pharmaceutical applications, but also limited the available suitable approaches that can be
used to enhance its bioavailability. Such limitations included the poor solubility, extreme
lipophiliciy causing poor formulation characteristics in addition to light and heat instability.
        
Figure 4. Flower and seeds of N.sativa and the structure of thymoquinone, the main component of N. sativa and many
other plants
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Triterpenoids are one of the most abundant natural products in plants. They exhibit huge
structural diversity as more than 90 different triterpenoidal carbon skeletons are known.
Further oxidative modifications and glycosidation of the skeleton generate even more diversity
[22]. Oleanolic (Figure 5a) and ursolic acids (Figure 5b) are among the well-known natural
occurring pentacyclic triterpenoids that widely exist in many food products and in more than
120 plant species [23]. Oleanolic acid (OA) is known to possess anti-inflammatory, antitumor,
antiviral, hepatoprotective and antihyperlipidemic effects. Moreover, it has been used in
Chinese traditional medicine to treat liver disorders for over twenty years. Ursolic acid (UA)
is also known to exhibit a wide and interesting biological activities including anti-inflamma‐
tory, anti-ulcer, antihyperlipidameic, antihyperglycaemic, hepatoprotective, neuroprotective
and anticacinogenic activities [23]. The oral bioavailability of these two natural triterpenoidal
acids is greatly limited by their very poor solubility in water. In fact, this drawback limits their
development as a medicine as well as their use in food, health and cosmetic products.
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Figure 5. Structures of a) oleanolic acid and b) ursolic acid
Asiatic acid (Figure 6) is another natural derivative of oleanolic acid. This compound is known
to be clinically effective on systemic scleroderma, abnormal scar formation and keloids [24].
Again, the poor solubility of this compound in water limits its bioavailability and hence hinders
its usage as a drug.
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Figure 6. Structure of Asiatic acid
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Cucurbitacins (Figure 7) resemble another class of triterpenes with interesting pharmaceutical
properties. Cucurbitacins are a group of highly oxidized tetracyclic triterpenoids that are
widely distributed in the plant kingdom and well recognized for their bitterness and toxicity.
Such compounds were initially isolated from plants belonging to the plant family Cucurbita‐
ceae, but were later found to be present, either as non-glycosylated or glycosylated in many
plant families including Brassicaceae, Scrophulariaceae, Begoniaceae, Elaeocarpaceae, Datiscaceae,
Desfontainiaceae, Polemoniaceae, Primulaceae, Rubiaceae, Sterculiaceae, Rosaceae and Thymelaea‐
ceae. In plants, cucurbitacins are known to act as heterologous chemical pheromones that
protect plants from external biological insults [25]. Moreover, these compounds are known to
possess a broad range of potent biological activity due to their cytotoxic properties. In
traditional medicine, cucurbitacins-containing plants have been known for their antipyretic,
analgesic, anti-inflammatory, antimicrobial, and antitumor activities [26].
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Figure 7. Basic structure of a cucurbitacin
There are 17 main molecules from cucurbitacin A to cucurbitacin T, and hundreds of com‐
pounds derived from them. Among them, cucurbitacins B, D, F, I and compounds derived
from them have been extenively investigated for their anticancer activities.
5. Alkaloids
Alkaloids are a highly diverse class of secondary metabolites, with more than 5000 compounds
being identified ranging from simple to highly complicated structures. These compounds
contain a ring structure and a nitrogen atom, in most cases, the nitrogen is part of a heterocyclic
ring structure. Alkaloids are known to exhibit significant biological activities. Examples
include the relieving action of ephedrine for asthma, the analgesic action of morphine and the
anticancer effects of vinblastine. Vinca alkaloids like vinblastine, vincristine, and vinorelbine
are widely used cytotoxic drugs that elicit their effects through disruption of microtubules,
resulting in metaphase arrest in dividing cells [27]. Thus, these compounds would benefit from
a controlled release dosage form that would result in a prolonged duration of exposure over
extended period of time. However, in spite of their significant bioactivities, these compounds
suffer from side effects. The major adverse effect of vinblastine is hematologic toxicity which
occurs much more frequently than with vincristine therapy. Other side effects include nausea,
vomiting and constipation, dyspnea, chest or tumor pain, wheezing and fever. Many recent
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publications dealt with loading vinca alkaloids in liposomal nanocarriers to lessen such side
effects [27, 28].
6. Nanoflora
As discussed above, herbal medicines are accompanied with many problems that prevent them
from reaching their full potential as pharmaceutical formulations. These problems include –
but not limited to: low solubility in water, low bioavailability, high toxicity and instability.
Nanotechnology has shown great promise for many medical applications such as cancer
diagnosis, chemotherapeutic drug delivery, and diabetes treatments [29]. This technology is
beneficial in overcoming some difficulties encountered with using bulk variable drug mole‐
cules in their synthetic and natural forms.
In the last decade, tremendous attentions have been paid on replacing synthetic drugs by
natural bioactive phytochemicals to eliminate synthetic drugs side effects. In order to reach
this goal, the above mentioned limitations need to be overcome. Nanotechnology can play an
important role in reducing or even eliminating such drawbacks. Such possibility will open the
door for a wide range of candidate compounds that were overlooked in the past due to these
limitations, to be revisited again. In this chapter, a systematic overview of the various methods
that can be applied to overcome one or more of these limitations and will lead finally to an
acceptable formulation composed mainly of the active phytochemical attached to or encapsu‐
lated in a nanocarrier system forming what will be known throughout this chapter as a
nanoflora. Such combination is capable of reaching the final phases of testing these active
compounds and be helpful in improving health care systems.
7. Nanotechnology and nanoparticles
Several nanoparticle systems have been used to aid in the formulation, encapsulation and
release of active compounds extracted or derived from natural resources. The main types of
these particles are liposomes, solid lipid nanoparticles, inorganic nanoparticles, micro-
emulsion, polymer nanoparticles, dendrimers and many other types.
7.1. Micelles and Liposomes
Micelles are spontaneous aggregates of amphiphiles (such as surfactants, Figure 8a) with
usually spherical structures with a size range of 5-25 nm (Figure 8b). Their core is usually
hydrophobic if they aggregate in polar media, however, they do form inverted micellar system
in non polar media with a hydrophilic core. Micelles are perfect carriers for drugs and have
been used more than any other system of nanoparticles [30]. Micelles come first in mind when
tackling solubility issues in aqueous media [31, 32]. The solubilization power of micelles has
been known and used for a long time especially as detergent. Their mechanism of action was
discovered in early 1900s. Micelles can be used as drug carriers and as solubilizing agents.
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However, they cannot be used to tackle other problems accompanying natural active com‐
pounds such as toxicity and stability since micellar systems are very dynamic ones and suffer
from fast clearance rate and stability issues. However, some of these disadvantages were to
some extent reduced via the preparation of polymeric micelles [33]. Polymeric micelles are
more stable with longer shelf life and stay longer in the body.
 
Insoluble 
drug
a 
b
Figure 8. a) Sketch of a lipid or surfactant molecule capable of forming micelles and liposomes with a polar head and
non-polar tail, b) Schematic presentation of a micelle with an insoluble drug encapsulated in the vicinity made by the
non-polar tails
Liposomes are spherical vesicles that are composed of lipid bilayer (Figure 9a). Liposomes
were discovered in 1961 by the British haematologist Alec Bangham and its resemblance to
the cell membrane attracted immediate attention [34, 35, 36]. The name liposome was derived
from the two Greek words lipo meaning fat and soma meaning body, which perfectly describes
these spherical objects that are made mainly from lipids. In some cases other constituents are
added to modify their chemical and physical properties (Figure 9b). Liposomes are easily
prepared by disturbing the lipid film in aqueous medium. This disturbance may be a result
from a large shear force produced via several techniques such as sonication. Liposomes are
different from micelles (Figure 9) in that they are composed of bilayer lipid membrane whereas
micelles are made from monolayer lipid vesicles.
There are different types of liposomes, including Small Unilamellar Vesicles (SUV, Figure
10b), Multilamellar Vesicles (MLV, Figure 10c), Large Unilamellar Vesicles (LUV, Figure
10d), Multivesicle Vesicles (MVV, Figure 10e) and cochleate vesicles (Figure 11). Each type of
liposome is formed depending on experimental conditions. In addition, a dominant liposome
type, size can be determined and/or made, after they are prepared via a series of extrusion
process accompanied by shear or via several freeze-thaw processes since these structures are
dynamic.
Liposomes are very important as drug carrier systems due to many factors including their
suitability to encapsulate polar and non polar drugs, their stability and long shelf life, con‐
trollable properties such as size and charge, ability to functionalize and modify the surface due
to the presence of many functional groups, and finally their biocompatibility and degradabil‐
ity. However, liposomes suffer from various disadvantages which include their short half-life
Nanoflora — How Nanotechnology Enhanced the Use of Active Phytochemicals
http://dx.doi.org/10.5772/58704
351
in the circulation system, although it can be enhanced by better controlling the size of the
liposome vesicle and modifying its composition. Even though liposomes are suitable to
encapsulate non polar drugs in the hydrophobic bilayer of the vesicle (Figure 9a and 10a),
sometimes, such drugs affect the integrity of these vesicles rendering them unsuitable for non
polar drugs.
Another promising type of nanoparticles is the phytosomes. The phospholipid in these types
of nanoparticles (considered mainly as liposomes) is covalently attached to the phytochemical.
Phytosomes are gaining increased interest and are the focus of more research to be used as
drug delivery systems [38, 39, 40].
 
a b c 
Figure 9. Basic structure of: a) bilayer lipid sheet, b) unilamellar liposome and c) optical micro-image of liposomes
loaded with Thymoquinone [37]
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Figure 10. Schematic representation of the different types of liposomes a) the lipid bilayer, b) Small Unilamellar Vesi‐
cle (SUV), c) Large Unilamellar Vesicle (LUV), d) Multi Lamellar Vesicle (MLV) and e) Multi Vesicle Vesicle (MVV).
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7.2. Solid Lipid Nanoparticles (SLN)
These are usually spherical structures composed of a lipid core, capable of solubilizing
lipophilic drugs, surrounded with surfactants that stabilizes the lipid core and can be used for
the hydrophilic drugs and other fictionalizations processes (Figure 12) [43]. SLN share other
types of nano-carriers’ their common advantages like their suitability to encapsulate non polar
insoluble drugs in its polymeric core, shielding the drug the outside environment - which could
be sometimes harsh - and as consequence increases the drug stability and reduces its toxicity
to the body. Other advantages include not only the ability to functionalize the SLN surface
with markers and targeting devices in order to enhance the targeting process, but also their
ability to produce a sustained and slow release of the drug in the targeted site. However, SLN
have advantages over other types of delivery systems in that they are easier to prepare, cheaper
and much easier for scale up productions.
Lipid drug 
loaded core 
Figure 12. Structure of Solid Lipid Nanoparticle (SLN) stabilized with surfactant molecules
 
 (a)                                               (b)                                                    (c) 
Figure 11. a) Optical micro image of cochleates [41], b) SEM image of cochleates [42], and c) freeze fracture electron
micrographs of cochleates cylinders [42]
Nanoflora — How Nanotechnology Enhanced the Use of Active Phytochemicals
http://dx.doi.org/10.5772/58704
353
7.3. Polymer Nanoparticles
Another type of particles that draw large attention is polymer nanoparticles [44]. These types
of nanoparticles (Figure 13) are easily made-mostly from biodegradable polymers and can
increase the stability and time of circulation. Moreover, in addition of being non toxic, other
advantages of these polymer nanoparticles include controlled drug release, biocompatability
and their suitability for scale up methods [45]. The most used two polymers include both poly
(lactide-co-glycolic acid) (PLGA) and poly (lactic acid) (PLA) [46]. Other polymers are also
good candidates to form polymeric nanoparticles and be suitable to act as drug carriers. These
include sugars [47], proteins [48] such as albumin [49], gelatin nanoparticles [50] and many
other naturally occurring macromolecules.
Figure 13. Schematic representation of polymer nanoparticles preparation [48]
Dendrimers are repetitive branched molecules attached to each other in a tree-like manner and
typically are symmetric around their core. They can also be categorized as polymeric nano‐
particles, and are characterized by their structural perfection, water solubility and monodis‐
persity. Dendrimers are good encapsulating agents for hydrophobic drugs due to their non
polar core.
7.4. Microemulsions (ME)
Microemulsions are usually made from oil, water, surfactant and a co-surfactant. They are
thermodynamically stable (in contrast to emulsions), transparent, and form spontaneously.
The particle size ranges from 10 to 100 nm, which enhances their penetration through cellular
membranes making microemulsions suitable as drug carriers. Due to the presence of polar and
non polar components in ME’s, they are very good solubilizing agents. Their properties can
be adjusted to suit the drug to be carried by optimizing compositions, types of both the
surfactant and the co-surfactant in addition of course to the oil used in the composition [51].
7.5. Inorganic nanoparticles
Inorganic nanoparticles such as gold nanoparticles, silver nanoparticles, ceramics, carbon
nanoparticles and nanotubes were the focus of very extensive research and in many fields.
Inorganic nanoparticles can be mainly classified into three different main categories including
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the: i) transition metal nanoparticles, ii) ceramics nanoparticles and iii) carbon nanoparticles
in addition to other types.
Transition metal nanoparticles (Figure 14) such as Au, Ti, Pt are gaining increasing interest in
the medical field [52]. There are many methods were transition metals can be applied in
medicine, drug delivery being one of them. For example, many transition metals can act as
drugs themselves when excited by light radiation. Depending on the excitation process and
the type of metal involved, when the absorbed energy is released, it can damage the DNA and/
or modify the protein, promote lipid peroxidation and destroy the cell microenvironment,
hence causing cell death. This method is promising in fighting cancer cells. Also, these
nanoparticles can be very powerful in imaging, which is very important in both diagnosis and
therapy monitoring [53]. One of the most promising nanoparticles in combating cancer is Au
nanoparticle [54]. However, these metals can be used as drug carriers. For example, Au shuttles
can be used for site specific delivery of toxic drugs [52]. However, these nanoparticles suffer
from loaming safety and clearance concerns. Metals in the nanometer scale range have special
properties and penetrations, making them very powerful catalysts that can trigger undesired
reaction. Nowadays, there are large concerns regarding safety of specifically metal nanopar‐
ticles and nanoparticles in general.
Figure 14. TEM images of metal nanoparticles with different geometries [55]
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Ceramics nanoparticles are mostly composed from oxides, nitrides and carbides with silica
(Figure 15) (SiO2) being the most used. Mainly they are used as hollow shells or cores that are
coated with biodegradable and biocompatible polymers. Such surface modifications improve
the properties of these nanoparticles especially for targeted delivery.
Figure 15. SEM images of silica nanoparticles with different sizes
8. Enhancing solubility and bioavailability
Low solubility of active phytochemicals is considered the main obstacle that hinders their
usage in pharmaceutical formulations. This is due to two main reasons; the first is that the
medium at which drugs work is mainly aqueous. Low solubility in aqueous media will
drastically lower the concentration of the drug causing a poor bioavailability. Nanoparticles
can provide an alternative medium for these drugs to be solubilized in and carried out through
the body to the targeted tissue or organ. The extensively small sizes of nanoparticles give high
surface area to volume ratio and as a result, more and more water molecules can surround the
particles and the solubility of hydrophobic compound is enhanced [56].
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Several nano-vesicles can be used to enhance the solubility such as micelles, liposomes, solid
lipid nanoparticles, polymer nanoparticles and many others [57]. Triptolide, is an example of
a bioactive diterpenoid epoxide ingredient isolated form Tripterygium wilfordii, a plant used in
traditional Chinese medicine. This compound was found to be active in vivo and in vitro mouse
models against polycystic kidney disease and against pancreatic cancer. It can also be used in
the treatment of autoimmune diseases especially rheumatoid arthritis, psoriasis, and leukemia.
However, it suffers from low solubility and high toxicity. In order to overcome its solubility
and toxicity issues, it was prepared as a biocompatible and biodegradable tripolide-loaded
poly [DL-lactic acid] nanoparticles [58]. It was also studied as a micro-emulsion system for
transdermal delivery.
The solubility of quercetin (a flavonoid that is naturally present in a wide range of fruits and
vegetables especially in onion, apples and many edible fruits) was enhanced 100 times after
encapsulation in polymeric nanoparticles suspensions [59].
Tetrandrine, bis-benzylisoquinoline alkaloid, exhibits antitumor activity and is known to acts
as a nonselective calcium channel blocker. This compound has very limited clinical applica‐
tions due to its poor water solubility. However, the solubility of this alkaloid was enhanced
as a result of its incorporation into SLN [60].
Cryptotanshinone is an active quinoid diterpene isolated from the roots of the Asian medicinal
plant, Salvia miotiorrhiza Bunge. This diterpene is known to exhibit variable interesting
pharmacological activities including anti-inflammatory, cytotoxic, anti-bacterial, anti-parasit‐
ic, anti-angiogenic and anti-oxidative activities but suffers from very low bioavailability as a
result of its extremely low water solubility. Cryptotanshinone oral bioavailability was highly
enhanced by introducing solid lipid nano-formulations [61].
Hypericin is a natural photosensitizer with limited ability to be used in diagnostic applications
because of its high hydrophobicity and limited solubility. Different nano-formulations like
hypericin-loaded solid lipid nanoparticles (Hy-SLN) and suspension of Hypericin-polymeric
nanoparticles have been developed in order to obtain better photo-detection and photody‐
namic therapy [57, 62].
Thymoquinone (Figure 4) is an active ingredient found in Black Seeds (N. sativa). It has
anticancer activity in addition to other therapeutic effects [13, 18, 63]. However, this compound
suffers from poor solubility and high hydrophobicity leading to poor formulations for
pharmaceutical applications. This problem was solved by encapsulating thymoquinone in
various carriers such as polymer nanoparticles [45], liposomes (Figure 16) [37] and in cyclo‐
dextrin (Figure 17) [64].
Bioavailability can also be enhanced due to encapsulation of drugs or active compounds in
nanocarriers. For example, ampelopsin, a flavonoid extracted from Ampelopsis grossedentata, is
known to possess many pharmacological activities including anti-inflammatory, antimicrobi‐
al, anticarcinogenic activities in addition to its antioxidation, antihypertension, hepatoprotec‐
tive and cough relieving effects. However, not only ampelopsin suffers from poor solubility
in water, it also has very low permeability. Ampelopsin was successfully encapsulated in a
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microemulsion that enhanced its bioavailability by both enhancing its solubility and penetra‐
tion through the intestinal mucosa [65].
 
(C) 
Figure 16. a) SEM, b) TEM and c) light microscope images of TQ-loaded liposomes [37]
Figure 17. TEM image of a nanoparticle of thymoquinone with cyclodextrin β [64]
9. Reduced toxicity and side effects
Most research focuses on reducing the toxicity and side effects of drugs, especially for those
used in chemotherapy. Many Nanoparticles systems can be used to encapsulate the toxic drug
and deliver it to specific sites in the body. These Nanoparticles are mainly made from biode‐
gradable, biocompatible materials such as natural polymers which include polysaccharides
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and proteins. For example, triptolide, which was mentioned previously to have anti-tumor
activity, has a side effect of being irritating to the gastric systems. Such gastric irritation can
be reduced by changing the nanoparticle carrier. When triptolide is encapsulated in Solid Lipid
Nanoparticles (SLN), such irritations are minimized [32]. Nanoparticles in general shield these
toxic drugs and isolate them until reaching their destination via targeted delivery mechanism.
Such mechanism of delivery depends on the capability to functionalize the surface of the
nanoparticle carriers.
Targeted drug delivery is deliberately increasing the concentration of the drug in specific part
of the body relative to other parts in order to increase the efficacy of drug and decrease the
side effects. The complex cellular network of organisms makes targeting a difficult mission.
There are variable methods of targeting such as modification of surface charge, inserting
ligands, and using biomarkers. The targeting mechanism can be divided into two mechanisms:
passive targeting and active targeting.
Passive targeting refers to the preferable accumulation of chemotherapeutic agent in solid
tumor as a result of enhanced vascular permeability of tumor tissue as compared to healthy
tissue [66].
Tumors have unique features, which make them distinct from normal tissue. The intact tissue
has non leaky microvasculars, while tumor tissue has leaky capillary beds. This situation
promotes the delivery and retention of drug loaded nonparticles through tumor tissue. This
phenomenon is recognized as the enhanced permeability and retention effect (EPR). The
hydrophobic surfaces of nanomaterials are highly susceptible to osponization and clearance
[66, 67]. When the surfaces were modified by becoming more hydrophilic, the rapid clearance
problems can be solved and longer circulation can be obtained because the hydrophilic coating
on the surfaces repels plasma and protein so drug loaded nanoparticles become invisible to
mononuclear phagocytic system (MPS).
Active targeting refers to the use of drug carriers with ligands (antibody, peptide) that are
selectively recognized by a receptor on the cell of interest. Since ligand-receptor interaction
can be highly selective, a more precise targeting is achieved with improved target cell recog‐
nition and target cell uptake [67].
Particle size and size distribution are the most important characteristics of nanoparticle
systems. Many studies have proved that nanometer particles are more effective and beneficial
than micrometer particles in drug delivery system. In nano scale, the surface area to volume
ratio is high; this situation makes the loaded drug less susceptible to reticular endothelial
system clearances. The nano-sized particles have better ability to penetrate through cells and
even small capillaries [68]. However, the ultimate small size of particles and large surface area
lead sometimes to limited drug loading and burst release pattern [69]. Surface modification
can be helpful in increasing residence time in the blood and reducing nonspecific distribu‐
tion.Unsuccessful surface modification ultimately is the main limiting factor for long-circu‐
lating nanoparticle systems [70].
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10. Enhanced activity
Encapsulation of active compounds into nanocarriers improves their activity. This might be
attributed to several factors such as enhanced solubility, better stability for both in vivo and in
vitro, and better formulation. However, the better penetration of the introduced nano systems
through cellular membrane via unique interaction mechanism is an additional factor that
participate in enhancing the bioactivity of drugs encapsulated in nanocarriers. For example,
Origanum dictamnus extracts are known to have antimicrobial and antioxidant properties due
to the presence of considerable concentrations of pehnolic compounds like flavones and
cumarines. Research showed that encapsulating this extract into liposomes improved its
activity [71].
11. Release profile
Obtaining constant drug release is considered an urgent necessity to obtain sustained drug
level in tumor tissue which can lead to a lower dose requirement. For example, paclitaxel
gelatin nanoparticles are highly effective in the treatment of bladder cancer because the rate
of paclitaxel release from paclitaxel gelatin nanoparticles is limited by the drug solubility in
aqueous medium. So the drug concentration remains constant and does not dilute when urine
production is increased [58].
Sometimes, a fast release rate is desired, accompanied with enhanced solubility and penetra‐
tion of non polar drugs. For example, Hibiscus rosa-sinensis and Murraya koenigii extracts are
acclaimed to prevent hair loss and promoting its growth. However, proving such claims
scientifically was hindered by many limitations, especially the poor solubility of the extracts
in water. Since the desired formulation is intended to be used as a topical treatment with fast
release rate to study its effectiveness, microemulsions were the ideal choice for improving the
solubility and systemically study the extracts of these plants [72].
12. Enhanced stability
The instability of most phytochemicals in bio environments results in quick degradation and
reduced activity. Encapsulation of such phytochemicals in carriers shields them from harsh
conditions that lead to their decomposition. Quercetin has a life time of only five minutes in
plasma whereas; quercetin loaded in liposomes modified with polyethylene glycol (PEG) has
a life time of more than five hours in plasma [73]. Quercetin was also encapsulated in polymeric
nanoparticles. Its antioxidant activity was maintained while its stability was highly enhanced
when encapsulated in eudragit nanoparticles (polymeric nanoparticles). This polymeric
nanoparticle protected quercetin and improved its stability in in acidic medium. However, the
polymeric nanoparticles released the antioxidant under neutral to basic conditions, making
Application of Nanotechnology in Drug Delivery360
such nanoparticles suitable for oral delivery of bioactive compounds and deliver them beyond
the acidic stomach environment [74].
13. Success stories
Nanotechnology is one of the most powerful tools in the modern life, as it has made a revo‐
lutionary impact in every aspect of human life. The speed by which nanomedicine has
advanced-particularly through the utilization of the various types of nanoparticles in the
prevention, diagnosis and treatment of many complex diseases like cancer-is fascinating. The
world is starting to witness the benefits of the application of nanotechnology in the field of
herbal/natural products’ drug delivery. One such benefit is Abraxane®. This drug is consid‐
ered as a major success story of the nanomedicine approach to treat cancer [3]. Abraxane, an
approved FDA drug, is a solvent free nano-version of the natural alkaloid, Taxol. Abraxane is
both more effective and less toxic and has been successful in addressing the solubility problem
associated with Paclitaxel (Taxol). Other examples of successful stories in the field of herbal
drug delivery are the two companies Cosmetochem and Indena. Cosmetochem launched
Herbasec® technology in the market. This product consists basically of liposomal encapsulat‐
ed, standardized botanical extracts that are used in cosmetics for their antioxidant effects for
the prevention of aging. Examples also include liposomal preparations of various herbal
constituents like extracts of White tea, Green tea, white hibiscus, Gurana and Aloe vera. Indena
commercializes the plant constituents/extracts of liquorice (18ß-glycyrrhetinic acid), Ammi
visnaga (visnadin), Centella asiatica (triterpenes), Ginkgo biloba (ginkgoflavonglucosides,
ginkgolides, bilobalide), Hawthorn flower (vitexin-2″-O-rhamnoside), milk thistle (silymarin
and Silybin), horse chestnut (escin ß-sitosterol), Terminalia sericea (sericoside), Panax ginseng
(ginsenosides), grape seed (polyphenols) and Green tea (polyphenols) [75]. Moreover, a long
list of recent patents on controlled release novel herbal formulations is becoming even longer
[76] proving that nanotechnology for drug delivery is becoming the future of phytochemicals
and opening the era for re-exploring and investigation the full potential power of traditional
herbal medicine represented either by the herbal extracts and/or their pure isolated phyto‐
chemicals.
14. Conclusions
The application of nanotechnology to drug delivery has already had a significant impact on
many areas of medicine. Currently, more than 20 nanoparticle therapeutics are in clinical use,
validating the ability of nanoparticles to improve the therapeutic index of drugs. In addition
to the already approved nanoparticles, numerous other nanoparticle platforms are currently
under various stages of preclinical and clinical development, including various liposomes,
polymeric micelles, dendrimers, quantum dots, gold nanoparticles, and ceramic nanoparticles.
More complex systems such as multifunctional nanoparticles that are concurrently capable of
targeting, imaging, and therapy are the subjects of future researches.
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Nanotechnology is offering several advantages to phytochemicals delivery and to drug
delivery in general [77]. Of the many advantages, the most important ones are:
• Enhancing solubility and bioavailability.
• Reducing toxicity and side effects of these phytochemicals, especially that most bioactive
phytochemicals are very toxic.
• Increasing the stability of active phytochemicals to stand harsh conditions along their way
to their site of action.
• Enhancing the biocompatibility and reducing the toxicity of the formulation itself, since
these nanocarriers limit the use of toxic non polar solvents that were traditionally used to
increase solubility and improve the formulation characteristics.
• However, an important thing that we must pay attention to, is the safety and hazards of
nanoparticles. In order to comprehend the safety of any formulation, long studies over a
long period of time is needed. Nanoparticles are relatively new in the medical market and
sector, and it is known that material in the nano scale usually has different properties
compared with bulk scale, making it difficult to predict hazards of such small particles.
The currently approved nanoparticle systems have in some cases improved the therapeu‐
tic index of drugs by reducing drug toxicity or enhancing drug efficacy. Future research
efforts need to be directed towards finding new methods for nanotoxicology, recognition
of  biological  effects  of  nanoparticles  in  the  environment,  and  creation  of  the  bases  of
nanobiomonitoring.
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